The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The influence of lead discovery strategies on the properties of drug candidates
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Rees, D. C., Congreve, Murray, C. W., & Carr, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1467 · Cited by 798
Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., Zheng, W., & Austin, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604348103 · Cited by 792
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
Recent Developments in Fragment-Based Drug Discovery
Congreve, M., Chessari, G., Tisi, D., & Woodhead, A. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000373 · Cited by 611
Functional group contributions to drug-receptor interactions
Andrews, P. R., Craik, D. J., & Martin, J. L. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a021 · Cited by 535
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Virtual screening strategies in drug discovery
McInnes, C. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.033 · Cited by 469
Ligand Binding Efficiency: Trends, Physical Basis, and Implications
Reynolds, C. H., Tounge, B. A., & Bembenek, S. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701255b · Cited by 319
Hit discovery and hit-to-lead approaches
Keserű, G. M., & Makara, G. M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.016 · Cited by 256
Self-citationDrugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
Critical review of the role of HTS in drug discovery
Macarron, R. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.02.001 · Cited by 241
Natural products as a screening resource
Harvey, A. L. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.012 · Cited by 223
High-Throughput Screening: Update on Practices and Success
Fox, S., Farr-Jones, S., Sopchak, L., Boggs, A., Nicely, H. W., Khoury, R., & Biros, M. (2006) · SLAS Discovery · doi:10.1177/1087057106292473 · Cited by 217
Edwards, P. D., Albert, J. S., Sylvester, M., Aharony, D., Andisik, D., Callaghan, O., Campbell, J. B., Carr, R. A., Chessari, G., Congreve, M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070829p · Cited by 214
Biological assay challenges from compound solubility: strategies for bioassay optimization
Di, L., & Kerns, E. H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.004 · Cited by 181
Congreve, M., Aharony, D., Albert, J. S., Callaghan, O., Campbell, J. B., Carr, R. A. E., Chessari, G., Cowan, S., Edwards, P. D., Frederickson, M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061197u · Cited by 144
Morphy, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512185 · Cited by 123
Coburn, C. A., Stachel, S. J., Li, Y., Rush, D. M., Steele, T. G., Chen-Dodson, E., Holloway, M. K., Xu, M., Huang, Q., Lai, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049388p · Cited by 117
Self-citationLead-like, drug-like or “Pub-like”: how different are they?
Oprea, T. I., Allu, T. K., Fara, D. C., Curpan, R. F., Ostopovici, L., & Bologa, C. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9105-3 · Cited by 114
Components of Successful Lead Generation
Davis, A., Keeling, D., Steele, J., Tomkinson, N. P., & Tinker, A. C. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053828411 · Cited by 110
(Research Papers) Design of a Compound Screening Collection for use in High Throughput Screening
Harper, G., Pickett, S. T. A., & Green, D. V. S. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620704772884832 · Cited by 77
Lead compounds discovered from libraries: Part 2
Gołȩbiowski, A., Klopfenstein, S. R., & Portlock, D. E. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00059-0 · Cited by 74
High Throughput Screening for Drug Discovery: Continually Transitioning into New Technology
Fox, S., Farr-Jones, S., & Yund, M. A. (1999) · SLAS DISCOVERY · doi:10.1177/108705719900400405 · Cited by 68
Fragment-Based Drug Discovery: What has it Achieved so Far?
Alex, A., & Flocco, M. M. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607782341082 · Cited by 65
Progress toward the discovery and development of efficacious BACE inhibitors.
Durham, T. B., & Shepherd, T. A. (2006) · PubMed · Cited by 64
Thiophene substituted acylguanidines as BACE1 inhibitors
Fobare, W. F., Solvibile, W. R., Robichaud, A. J., Malamas, M. S., Manas, E. S., Turner, J., Hu, Y., Wagner, E. J., Chopra, R., Cowling, R. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.010 · Cited by 60
Tyramine fragment binding to BACE-1
Kuglstatter, A., Ståhl, M., Peters, J., Huber, W., Stihle, M., Schlatter, D., Benz, J., Ruf, A., Roth, D., Enderle, T., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.032 · Cited by 55
High-Throughput Screening: Searching for Higher Productivity
Fox, S., Farr-Jones, S., Sopchak, L., Boggs, A. F., & Comley, J. C. W. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265290 · Cited by 51
Parker, C. N., & Bajorath, J. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200610069 · Cited by 23
How can we avoid the productivity gap?
Carney, S. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03533-6 · Cited by 20
Cited by
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Impact of high-throughput screening in biomedical research
Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V. S., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3368 · Cited by 1,364
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C., & Boeckler, F. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012068 · Cited by 1,331
Metadata
- Authors
- Keserü, G. M., & Makara, G. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-03
- Volume
- 8
- Issue
- 3
- Pages
- 203-212
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1978009405
- Cited by
- 628
- References
- 38
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.